Comment on: Perceptions of bariatric surgery in patients with T2DM: Data from a self-administered questionnaire

AAT reports the following: Grants from Novo Nordisk and Sanofi; personal fees from Novo Nordisk, Janssen, AZ, Eli Lilly, BI, BMS, NAPP, MSD, Nestle, Gilead, Sanofi; as well as non-financial support from Novo Nordisk, Eli Lilly, AZ, Impeto medical, Resmed, Aptiva, BI, BMS, NAPP, MSD. AAT is currently an employee of Novo Nordisk A/S but Novo Nordisk A/S had no involvement in this work. The views detailed in this editorial are those of the author and not those of any of the employers or the funders.
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Source Type: research